Prof Kelly Phillips
Honorary (Professorial Fellow)
The Sir Peter MacCallum Department of Oncology
348 Scholarly works
30 Projects
HIGHLIGHTS
2026
Research grants (ARC, NHMRC, MRFF)
Precision Prevention, Targeted Treatment and Improved Survivorship to Decrease the Burden of Breast Cancer
2024
Journal article
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
DOI: 10.1186/s12943-024-02048-12022
Journal article
Checkpoint inhibitor immunotherapy diminishes oocyte number and quality in mice.
DOI: 10.1038/s43018-022-00413-x2021
Journal article
Assessment of Ovarian Function in Phase 3 (Neo)adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation.
DOI: 10.1093/jnci/djab1112021
Journal article
Breast Cancer Chemoprevention: Use and Views of Australian Women and Their Clinicians.
DOI: 10.1158/1940-6207.capr-20-03692021
Research grants (ARC, NHMRC, MRFF)
Reducing the Burden of Breast Cancer Through Precision Prevention, Targeted Treatment and Enhanced Survivorship
2021
Research Grant
A New Way to Deliver Breast Cancer Prevention
RECENT SCHOLARLY WORKS
2026
Journal article
Risks of non-breast, non-ovarian cancers for BRCA1 and BRCA2 pathogenic variant carriers: a prospective cohort study
DOI: 10.1186/s12916-026-04753-82026
Journal article
Radiation therapy management in BRCA1/2 carriers diagnosed with early breast cancer: An international cohort study
DOI: 10.1016/j.radonc.2026.1115232026
Journal article
Unlocking the Potential of Risk-Based Screening for Breast Cancer: From Detection to Prevention
DOI: 10.1001/jama.2025.248172026
Journal article
Association between type and location of germline BRCA1/2 pathogenic or likely pathogenic variants with phenotype and prognosis in young patients with breast cancer: results from an international cohort study
DOI: 10.1016/j.annonc.2025.11.0042026
Journal article
Abstract RF5-03: OlympiaN: a phase 2, multicenter, open-label study to assess the efficacy and safety of neoadjuvant olaparib monotherapy and olaparib plus durvalumab in patients with BRCA mutations and early-stage HER2-negative breast cancer
DOI: 10.1158/1557-3265.sabcs25-rf5-032026
Journal article
Abstract PD7-11: Impact of neoadjuvant pembrolizumab on ovarian function in young patients with triple-negative breast cancer (TNBC): Longitudinal analysis from NeoSTOP and NeoPACT trials
DOI: 10.1158/1557-3265.sabcs25-pd7-112026
Journal article
Parity and lactation induce T-cell-mediated breast cancer protection
DOI: 10.1038/s41586-025-09713-52025
Journal article
Breastfeeding after breast cancer in young BRCA carriers
DOI: 10.1093/jnci/djaf177